Abstract Presenter Registration—Deadline May 24. Register now.Change of Presenting Authors? Contact Katie Hamel
Call for Soapbox Presenters—Deadline June 5Share your ideas and innovations with potential investors/partners as a presenter. Learn more.
Program Previews!Get a sneak peak on topics being covered at #CRSboston. View video.
Welcome to the new President's Blog. Keep up-to-date on CRS Boston and more with reflections by Ruth Schmid.
Featured Content from the Newsletter
Exploring Possibilities of Microneedles with Ryan DonnellyProf. Ryan Donnelly is the Chair of Pharmaceutical Technology at Queen’s University, Belfast, U.K. He is a young and dynamic researcher in the field of transdermal delivery with primary focus on microneedle drug delivery and applications. Prof. Donnelly’s research is centered on design and physicochemical characterization of advanced polymeric drug delivery systems for transdermal and topical drug delivery, with a strong emphasis on improving therapeutic outcomes for patients. The bioadhesive patch he developed during his Ph.D. studies was shown to be successful in the clinic for photodynamic therapy of over 100 patients with neoplastic and dysplastic gynecological conditions, and the patent was subsequently licensed to Swedish Pharma AB. Prof. Donnelly’s current research is focused on novel polymeric microneedle arrays for transdermal administration of “difficult-to-deliver” drugs and intradermal delivery of vaccines and photosensitizers.
CRS Vision Statement:Visionary leadership in delivery science and technology. CRS Mission Statement:CRS is an international, multidisciplinary society dedicated to delivery science and technology.